Submission of Intimation of Preferential Issue.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 11.0 pts more than Nifty Microcap 250 and 11.0 pts more than its Healthcare Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board of Novelix Pharmaceuticals Ltd (formerly Trimurthi Limited) approved a preferential allotment of 12,00,000 equity shares to 18 non-promoter (public) investors to raise additional capital. The shares will be issued at Rs. 57 each — a face value of Rs. 10 plus a premium of Rs. 47 per share — aggregating to Rs. 6.84 crore. Allottees are individual public investors with allocations ranging from 25,000 to 150,000 shares each. The decision is subject to shareholder approval at an Extra Ordinary General Meeting and compliance with SEBI and Companies Act provisions.
This is a small equity dilution of about Rs. 6.84 crore to a group of small individual investors, with no institutional or marquee participation. Shareholders may see mild dilution, and the share price could face short-term pressure depending on the prevailing market price versus the issue price of Rs. 57.